The company delivers 26% year-over-year revenue growth with exceptional cash conversion and a consistent earnings beat track record, but the stock has already surpassed its price target and trades within 0.2% of its 52-week high — the reward-to-risk ratio has turned unfavorable and the setup favors trimming rather than adding.
Thesis pillars
- Strong Revenue Growth Momentum→Stable
- Exceptional Cash Conversion→Stable
- Stock Priced Above Target↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026
BrightSpring Health Services, I (BTSG) Stock Analysis
Healthcare · Health Information Services
Wait for pullback to $57.65. Weak momentum — blocks BUY_NOW at $59.46. Engine's entry $57.65 (Atr Pullback Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4); Leverage penalty (D/E 1.2): -0.5.
BrightSpring Health Services delivers pharmacy and provider services to complex patients in home and community settings across all 50 states, serving over 465,000 patients daily. Revenue comes from Medicare, Medicaid, and commercial insurer reimbursement across Pharmacy... Read more
Wait for pullback to $57.65. Weak momentum — blocks BUY_NOW at $59.46. Engine's entry $57.65 (Atr Pullback Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4); Leverage penalty (D/E 1.2): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 1 day. Wait until post-earnings. Score 5.9/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 1d<=7d. Suitability: aggressive.
About BrightSpring Health Services, I
About BrightSpring Health Services, I
BrightSpring Health Services served over 465,000 patients daily across all 50 states in 2025, operating through more than 175 pharmacies and filling 43 million prescriptions during the year. The company's approximately 10,500 clinical providers and pharmacists also delivered 21 million hours of home health, hospice, rehab, and supportive care. Approximately 53% of revenues were concentrated in 10 states with favorable demographics and regulatory environments.
The company generates revenue through two segments: Pharmacy Solutions, which served over 410,000 patients through more than 4,500 unique customer and payor contracts across 6,600 customer locations in 2025; and Provider Services, which delivers clinical home health, hospice, rehab therapy, and personal care to approximately 16,000 Senior and Specialty patients. On March 30, 2026, BrightSpring completed the divestiture of its Community Living business to National Mentor Holdings for $835 million, narrowing Provider Services to clinical and supportive care. Payer mix is heavily weighted toward Medicare, Medicaid, and commercial insurance, with managed care organizations increasingly intermediating reimbursements under capitation models. The Pharmacy Solutions segment holds access to 149 limited-distribution oncology drugs with 18 more in the launch pipeline, creating preferred channel relationships with pharmaceutical manufacturers.
Show full overview
Medicare and Medicaid reimbursement risk is the dominant financial exposure: CMS can reduce base prospective payment rates, eliminate annual rate increases, change case-mix thresholds, or reclassify home health resource groups — each of which may impact revenue. The Review Choice Demonstration, running through 2029, subjects home health agencies in Illinois, Ohio, North Carolina, Florida, Oklahoma, and Texas to pre-claim review, increasing administrative costs and potentially delaying payments. With more than half of Medicare beneficiaries enrolled in Medicare Advantage plans as of January 2025, MCO contracts — terminable on 60 days' notice — add further rate pressure.
See also: Healthcare · Health Information Services
From BrightSpring Health Services, I's most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-10-29Recent Developments — BrightSpring Health Services, I
Latest news
- NEWS BrightSpring CEO Jon B. Rousseau Withholds 36,355 Shares for Tax on RSU Vesting - Kalkine Media — Kalkine Media neutral
- NEWS BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance — Yahoo Finance positive
- NEWS Form 4 Brightspring Health Services Inc: Jon B. Rousseau (Director, Officer) For: 25 October - Investing.com India — Investing.com India neutral
- NEWS Form 4 Brightspring Health Services Inc: Jon B. Rousseau (Director, Officer) For: 25 October By Investing.com - Investin — Investing.com India neutral
- NEWS Form 4 Brightspring Health Services Inc: Jon B. Rousseau (Director, Officer) For: 25 October - Investing.com Canada — Investing.com Canada neutral
Generated 2026-10-29T11:53:50Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographic10 states53%10-K Item 1: 'approximately 53% of our revenue in 10 states for the year ended December 31, 2025'
- MEDIUMCustomerMedicare and Medicaid10-K Item 1A: 'We derive substantial revenue from government healthcare programs, primarily Medicare and Medicaid.'
Material Events(8-K, last 90d)
- 2026-03-31Item 2.01MEDIUMBrightSpring completed the divestiture of its Community Living business to National Mentor Holdings, Inc. for $835 million on March 30, 2026, as previously disclosed January 17, 2025.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $57.65. Weak momentum — blocks BUY_NOW at $59.46. Engine's entry $57.65 (Atr Pullback Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4); Leverage penalty (D/E 1.2): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 1 day. Wait until post-earnings. Target $71.05 (+19.5%), stop $54.22 (−9.7%), A.R:R 3.3:1. Score 5.9/10, moderate confidence.
Take-profit target: $71.05 (+19.5% upside). Target $71.05 (+19.5%), stop $54.22 (−9.7%), A.R:R 3.3:1. Stop-loss: $54.22.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4); Leverage penalty (D/E 1.2): -0.5; Negative momentum.
BrightSpring Health Services, I trades at a P/E of 52.6 (forward 26.1). TrendMatrix value score: 6.1/10. Verdict: Buy (Wait for Entry).
25 analysts cover BTSG with a consensus score of 4.3/5. Average price target: $79.
What does BrightSpring Health Services, I do?BrightSpring Health Services delivers pharmacy and provider services to complex patients in home and community settings...
BrightSpring Health Services delivers pharmacy and provider services to complex patients in home and community settings across all 50 states, serving over 465,000 patients daily. Revenue comes from Medicare, Medicaid, and commercial insurer reimbursement across Pharmacy Solutions (43 million prescriptions in 2025) and Provider Services segments.